Literature DB >> 2004451

Macromolecular creatine kinase type 1: a serum marker associated with disease.

M Laureys1, J P Sion, H Slabbynck, L Steenssens, C Cobbaert, M P Derde, F K Gorus.   

Abstract

The prevalence of circulating macromolecular creatine kinase type 1 (macro CK type 1 or CK-immunoglobulin complexes) is significantly higher in a patient population selected for CK isoenzyme assay than in age- and sex-matched blood donors (n = 1304). In greater than 8000 patients studied, 49 individuals with macro CK type 1 were identified, yielding an overall prevalence of 0.61%. Macro CK type 1 complexes occurred more frequently in women and in patients older than 70 years, and were often associated with complications of cardiovascular disease, life-threatening conditions, and poor outcome. These latter clinical associations could arise, at least partly, from the selection of patients for whom CK isoenzyme analysis was ordered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004451

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease.

Authors:  J L Perez-Calle; I Marin-Jimenez; P Lopez-Serrano; J P Gisbert; A S Pena; C Fernandez-Rodriguez
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

2.  Serum macromolecular creatine kinase type 1 as a diagnostic clue in inflammatory bowel disease?

Authors:  K Martin Hoffmann; Marlene Grillitsch; Andrea Deutschmann; Christoph Högenauer; Tatjana Stojakovic; Almuthe C Hauer
Journal:  Eur J Pediatr       Date:  2013-01-18       Impact factor: 3.183

3.  Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.

Authors:  F K Gorus; J C Sodoyez; D G Pipeleers; B Keymeulen; A Foriers; C F Van Schravendijk
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

4.  Clinical role of recurrently elevated macro creatine kinase type 1.

Authors:  Ju-Feng Hsiao; Hsiao-Chen Ning; Po-Wen Gu; Wei-Yee Lin; Pao-Hsien Chu
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

5.  Levels of C-reactive protein, creatine kinase-muscle and aldolase A are suitable biomarkers to detect the risk factors for osteoarthritic disorders: A novel diagnostic protocol.

Authors:  Apurba Ganguly
Journal:  Caspian J Intern Med       Date:  2019

6.  Management of muscular dystrophy during osteoarthritis disorder: A topical phytotherapeutic treatment protocol.

Authors:  Apurba Ganguly
Journal:  Caspian J Intern Med       Date:  2019
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.